Cost effectiveness of case-finding strategies for primary prevention of cardiovascular disease: a modelling study
Cost effectiveness of case-finding strategies for primary prevention of cardiovascular disease: a modelling study
Background: Policies of active case finding for cardiovascular disease (CVD) prevention in healthy adults are common, but economic evaluation has not investigated targeting such strategies at those who are most likely to benefit.
Aim: To assess the cost effectiveness of targeted case finding for CVD prevention.
Design and setting: Cost-effectiveness modelling in an English primary care population.
Method: A cohort of 10 000 individuals aged 30–74 years and without existing CVD or diabetes was sampled from The Health Improvement Network database, a large primary care database. A discrete-event simulation was used to model the process of inviting people for assessment, assessing cardiovascular risk, and initiation and persistence with drug treatment. Risk factors and drug cessation rates were obtained from primary care data. Published sources provided estimates of uptake of assessment, treatment initiation, and treatment effects. The researchers determined the lifetime costs and quality-adjusted life years (QALYs) with opportunistic case finding, and strategies prioritising and targeting patients by age or prior estimate of cardiovascular risk. This study reports on the optimum strategy if a QALY is valued at £20 000.
Results: Compared with no case finding, inviting all adults aged 30–74 years in a population of 10 000 yields 30.32 QALYs at a total cost of £705 732. The optimum strategy is to rank patients by prior risk estimate and invite 8% of those who are assessed as being at highest risk (those at ?12.76% predicted 10-year CVD risk), yielding 17.53 QALYs at a cost of £162 280. There is an 89.4% probability that the optimum strategy is to invite <35% of patients for assessment.
Conclusion: Across all age ranges, targeted case finding using a prior estimate of CVD risk is more efficient than universal case finding in healthy adults
1-12
Crossan, Catriona
618fb461-ecd2-47da-9b50-82b136ad28b6
Lord, Joanne
fd3b2bf0-9403-466a-8184-9303bdc80a9a
Ryan, Ronan
3442cbb8-383e-45d2-a8a0-d23c0e24909f
Nherera, Leo
01bd40bc-dce4-4603-9697-ef6d8b20669b
Marshall, Tom
01ede45b-09dc-4ed0-8971-ecb9d7e7b2ac
Crossan, Catriona
618fb461-ecd2-47da-9b50-82b136ad28b6
Lord, Joanne
fd3b2bf0-9403-466a-8184-9303bdc80a9a
Ryan, Ronan
3442cbb8-383e-45d2-a8a0-d23c0e24909f
Nherera, Leo
01bd40bc-dce4-4603-9697-ef6d8b20669b
Marshall, Tom
01ede45b-09dc-4ed0-8971-ecb9d7e7b2ac
Crossan, Catriona, Lord, Joanne, Ryan, Ronan, Nherera, Leo and Marshall, Tom
(2016)
Cost effectiveness of case-finding strategies for primary prevention of cardiovascular disease: a modelling study.
British Journal of General Practice, .
(doi:10.3399/bjgp16X687973).
(PMID:27821671)
Abstract
Background: Policies of active case finding for cardiovascular disease (CVD) prevention in healthy adults are common, but economic evaluation has not investigated targeting such strategies at those who are most likely to benefit.
Aim: To assess the cost effectiveness of targeted case finding for CVD prevention.
Design and setting: Cost-effectiveness modelling in an English primary care population.
Method: A cohort of 10 000 individuals aged 30–74 years and without existing CVD or diabetes was sampled from The Health Improvement Network database, a large primary care database. A discrete-event simulation was used to model the process of inviting people for assessment, assessing cardiovascular risk, and initiation and persistence with drug treatment. Risk factors and drug cessation rates were obtained from primary care data. Published sources provided estimates of uptake of assessment, treatment initiation, and treatment effects. The researchers determined the lifetime costs and quality-adjusted life years (QALYs) with opportunistic case finding, and strategies prioritising and targeting patients by age or prior estimate of cardiovascular risk. This study reports on the optimum strategy if a QALY is valued at £20 000.
Results: Compared with no case finding, inviting all adults aged 30–74 years in a population of 10 000 yields 30.32 QALYs at a total cost of £705 732. The optimum strategy is to rank patients by prior risk estimate and invite 8% of those who are assessed as being at highest risk (those at ?12.76% predicted 10-year CVD risk), yielding 17.53 QALYs at a cost of £162 280. There is an 89.4% probability that the optimum strategy is to invite <35% of patients for assessment.
Conclusion: Across all age ranges, targeted case finding using a prior estimate of CVD risk is more efficient than universal case finding in healthy adults
Text
bjgpJan-2017-67-654-Marshall_FL (3).pdf
- Version of Record
Restricted to Repository staff only
Request a copy
More information
Accepted/In Press date: 9 August 2016
e-pub ahead of print date: 8 November 2016
Organisations:
Faculty of Medicine
Identifiers
Local EPrints ID: 402787
URI: http://eprints.soton.ac.uk/id/eprint/402787
ISSN: 0960-1643
PURE UUID: 9a6aa052-dad3-403b-a735-5a36571eda7d
Catalogue record
Date deposited: 15 Nov 2016 14:39
Last modified: 15 Mar 2024 03:52
Export record
Altmetrics
Contributors
Author:
Catriona Crossan
Author:
Ronan Ryan
Author:
Leo Nherera
Author:
Tom Marshall
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics